1541 related articles for article (PubMed ID: 21729180)
21. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
[TBL] [Abstract][Full Text] [Related]
22. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
23. CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model.
Deurloo DT; van Esch BC; Hofstra CL; Nijkamp FP; van Oosterhout AJ
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):751-60. PubMed ID: 11726402
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma.
Wang Y; McCusker CT
Clin Exp Allergy; 2005 Aug; 35(8):1104-11. PubMed ID: 16120094
[TBL] [Abstract][Full Text] [Related]
25. Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma.
Wegmann M; Göggel R; Sel S; Sel S; Erb KJ; Kalkbrenner F; Renz H; Garn H
Am J Respir Cell Mol Biol; 2007 Jan; 36(1):61-7. PubMed ID: 16917075
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of a murine model for allergic asthma using allergen-specific IgE monoclonal antibody to study pathological roles of IgE.
Mizutani N; Goshima H; Nabe T; Yoshino S
Immunol Lett; 2012 Jan; 141(2):235-45. PubMed ID: 22037571
[TBL] [Abstract][Full Text] [Related]
27. Panax ginseng ameliorates airway inflammation in an ovalbumin-sensitized mouse allergic asthma model.
Kim DY; Yang WM
J Ethnopharmacol; 2011 Jun; 136(1):230-5. PubMed ID: 21549818
[TBL] [Abstract][Full Text] [Related]
28. Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma.
Moerch U; Haahr Hansen M; Vest Hansen NJ; Rasmussen LK; Oleksiewicz MB; Frandsen TP; Haurum JS; Bregenholt S
Int Arch Allergy Immunol; 2006; 140(3):261-9. PubMed ID: 16699287
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.
Bao ZS; Hong L; Guan Y; Dong XW; Zheng HS; Tan GL; Xie QM
Int Immunopharmacol; 2011 Aug; 11(8):899-906. PubMed ID: 21354484
[TBL] [Abstract][Full Text] [Related]
30. Effects of taraxasterol on ovalbumin-induced allergic asthma in mice.
Liu J; Xiong H; Cheng Y; Cui C; Zhang X; Xu L; Zhang X
J Ethnopharmacol; 2013 Jul; 148(3):787-93. PubMed ID: 23727181
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of Cissampelos sympodialis and its isolated alkaloid warifteine in airway hyperreactivity and lung remodeling in a mouse model of asthma.
Bezerra-Santos CR; Vieira-de-Abreu A; Vieira GC; Filho JR; Barbosa-Filho JM; Pires AL; Martins MA; Souza HS; Bandeira-Melo C; Bozza PT; Piuvezam MR
Int Immunopharmacol; 2012 Jun; 13(2):148-55. PubMed ID: 22480776
[TBL] [Abstract][Full Text] [Related]
32. Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice.
Takeda M; Ito W; Tanabe M; Ueki S; Kato H; Kihara J; Tanigai T; Chiba T; Yamaguchi K; Kayaba H; Imai Y; Okuyama K; Ohno I; Sasaki T; Chihara J
J Allergy Clin Immunol; 2009 Apr; 123(4):805-12. PubMed ID: 19232703
[TBL] [Abstract][Full Text] [Related]
33. Female mice are more susceptible to the development of allergic airway inflammation than male mice.
Melgert BN; Postma DS; Kuipers I; Geerlings M; Luinge MA; van der Strate BW; Kerstjens HA; Timens W; Hylkema MN
Clin Exp Allergy; 2005 Nov; 35(11):1496-503. PubMed ID: 16297148
[TBL] [Abstract][Full Text] [Related]
34. Histamine type 1 receptor deficiency reduces airway inflammation in a murine asthma model.
Miyamoto K; Iwase M; Nyui M; Arata S; Sakai Y; Gabazza EC; Kimura H; Homma I
Int Arch Allergy Immunol; 2006; 140(3):215-22. PubMed ID: 16685135
[TBL] [Abstract][Full Text] [Related]
35. Protocatechuic acid suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.
Wei M; Chu X; Guan M; Yang X; Xie X; Liu F; Chen C; Deng X
Int Immunopharmacol; 2013 Apr; 15(4):780-8. PubMed ID: 23357785
[TBL] [Abstract][Full Text] [Related]
36. Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens.
Brandt EB; Scribner TA; Akei HS; Rothenberg ME
J Allergy Clin Immunol; 2006 Aug; 118(2):420-7. PubMed ID: 16890767
[TBL] [Abstract][Full Text] [Related]
37. [Dynamic changes in airway hyperresponsiveness as a result of allergen and therapeutic effects of budesonide in rats].
Gong PH; Gao ZC; Hu P; Dong JQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Aug; 17(8):463-7. PubMed ID: 16105423
[TBL] [Abstract][Full Text] [Related]
38. Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma.
Agrawal DK; Edwan J; Kandimalla ER; Yu D; Bhagat L; Wang D; Agrawal S
Int Immunopharmacol; 2004 Jan; 4(1):127-38. PubMed ID: 14975367
[TBL] [Abstract][Full Text] [Related]
39. Sites of allergic airway smooth muscle remodeling and hyperresponsiveness are not associated in the rat.
Siddiqui S; Jo T; Tamaoka M; Shalaby KH; Ghezzo H; Bernabeu M; Martin JG
J Appl Physiol (1985); 2010 Oct; 109(4):1170-8. PubMed ID: 20651225
[TBL] [Abstract][Full Text] [Related]
40. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
